Back to Search Start Over

Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunction.

Authors :
Senatorov VV Jr
Friedman AR
Milikovsky DZ
Ofer J
Saar-Ashkenazy R
Charbash A
Jahan N
Chin G
Mihaly E
Lin JM
Ramsay HJ
Moghbel A
Preininger MK
Eddings CR
Harrison HV
Patel R
Shen Y
Ghanim H
Sheng H
Veksler R
Sudmant PH
Becker A
Hart B
Rogawski MA
Dillin A
Friedman A
Kaufer D
Source :
Science translational medicine [Sci Transl Med] 2019 Dec 04; Vol. 11 (521).
Publication Year :
2019

Abstract

Aging involves a decline in neural function that contributes to cognitive impairment and disease. However, the mechanisms underlying the transition from a young-and-healthy to aged-and-dysfunctional brain are not well understood. Here, we report breakdown of the vascular blood-brain barrier (BBB) in aging humans and rodents, which begins as early as middle age and progresses to the end of the life span. Gain-of-function and loss-of-function manipulations show that this BBB dysfunction triggers hyperactivation of transforming growth factor-β (TGFβ) signaling in astrocytes, which is necessary and sufficient to cause neural dysfunction and age-related pathology in rodents. Specifically, infusion of the serum protein albumin into the young rodent brain (mimicking BBB leakiness) induced astrocytic TGFβ signaling and an aged brain phenotype including aberrant electrocorticographic activity, vulnerability to seizures, and cognitive impairment. Furthermore, conditional genetic knockdown of astrocytic TGFβ receptors or pharmacological inhibition of TGFβ signaling reversed these symptomatic outcomes in aged mice. Last, we found that this same signaling pathway is activated in aging human subjects with BBB dysfunction. Our study identifies dysfunction in the neurovascular unit as one of the earliest triggers of neurological aging and demonstrates that the aging brain may retain considerable latent capacity, which can be revitalized by therapeutic inhibition of TGFβ signaling.<br /> (Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)

Details

Language :
English
ISSN :
1946-6242
Volume :
11
Issue :
521
Database :
MEDLINE
Journal :
Science translational medicine
Publication Type :
Academic Journal
Accession number :
31801886
Full Text :
https://doi.org/10.1126/scitranslmed.aaw8283